These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17118480)

  • 1. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes.
    Zhang H; Liu X; Kuang H; Yi R; Xing H
    Diabetes Res Clin Pract; 2007 Jul; 77(1):58-61. PubMed ID: 17118480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients.
    Feng Y; Mao G; Ren X; Xing H; Tang G; Li Q; Li X; Sun L; Yang J; Ma W; Wang X; Xu X
    Diabetes Care; 2008 Oct; 31(10):1939-44. PubMed ID: 18599530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
    Rafiq M; Flanagan SE; Patch AM; Shields BM; Ellard S; Hattersley AT;
    Diabetes Care; 2008 Feb; 31(2):204-9. PubMed ID: 18025408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic control in type 2 diabetes is associated with sulfonylurea receptor-1 (SUR-1) but not with KCNJ11 polymorphisms.
    Nikolac N; Simundic AM; Katalinic D; Topic E; Cipak A; Zjacic Rotkvic V
    Arch Med Res; 2009 Jul; 40(5):387-92. PubMed ID: 19766903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
    He YY; Zhang R; Shao XY; Hu C; Wang CR; Lu JX; Bao YQ; Jia WP; Xiang KS
    Acta Pharmacol Sin; 2008 Aug; 29(8):983-9. PubMed ID: 18664331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.
    Meirhaeghe A; Helbecque N; Cottel D; Arveiler D; Ruidavets JB; Haas B; Ferrières J; Tauber JP; Bingham A; Amouyel P
    Am J Med Genet; 2001 Jun; 101(1):4-8. PubMed ID: 11343328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliclazide modified release: from once-daily administration to 24-hour blood glucose control.
    Harrower A
    Metabolism; 2000 Oct; 49(10 Suppl 2):7-11. PubMed ID: 11078469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
    Owecki M; Horst-Sikorska W; Kaczmarek M; Słomski R; Sowiński J
    Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy.
    Nikolac N; Simundic AM; Saracevic A; Katalinic D
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):924-30. PubMed ID: 22533711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.
    Hamming KS; Soliman D; Matemisz LC; Niazi O; Lang Y; Gloyn AL; Light PE
    Diabetes; 2009 Oct; 58(10):2419-24. PubMed ID: 19587354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.
    Javorsky M; Klimcakova L; Schroner Z; Zidzik J; Babjakova E; Fabianova M; Kozarova M; Tkacova R; Salagovic J; Tkac I
    Eur J Intern Med; 2012 Apr; 23(3):245-9. PubMed ID: 22385882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients.
    Dworacka M; Winiarska H; Jagodziński PP
    Diabetes Res Clin Pract; 2007 Aug; 77(2):258-62. PubMed ID: 17207885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
    Zychma MJ; Gumprecht J; Strojek K; Grzeszczak W; Moczulski D; Trautsolt W; Karasek D
    Med Sci Monit; 2002 Jul; 8(7):CR512-5. PubMed ID: 12118200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the relationship between sulfonylurea receptor 1 gene polymorphism and type 2 diabetes mellitus].
    Wang JS; Zhou L; Cheng JL; Shen MY
    Yi Chuan; 2004 Jan; 26(1):8-12. PubMed ID: 15626659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
    Sperling MA
    N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.
    Florez JC; Burtt N; de Bakker PI; Almgren P; Tuomi T; Holmkvist J; Gaudet D; Hudson TJ; Schaffner SF; Daly MJ; Hirschhorn JN; Groop L; Altshuler D
    Diabetes; 2004 May; 53(5):1360-8. PubMed ID: 15111507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on association between gestational diabetes mellitus and sulfonylurea receptor-1 gene polymorphism].
    Niu XM; Yang H; Zhang HY; Li NJ; Qi XM; Chang Y; Chang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):159-63. PubMed ID: 15840308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas.
    Sato R; Watanabe H; Genma R; Takeuchi M; Maekawa M; Nakamura H
    Pharmacogenomics; 2010 Dec; 11(12):1743-50. PubMed ID: 21142918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
    Lang VY; Fatehi M; Light PE
    Pharmacogenet Genomics; 2012 Mar; 22(3):206-14. PubMed ID: 22209866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.